We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Test 24 Hours After Start of Chemotherapy Predicts Survival

By LabMedica International staff writers
Posted on 11 Jan 2023
Print article
Image: A new method can quickly predict if certain cancer patients will survive or not after chemotherapy (Photo courtesy of Pexels)
Image: A new method can quickly predict if certain cancer patients will survive or not after chemotherapy (Photo courtesy of Pexels)

Acute myeloid leukemia is an aggressive blood cancer with poor survival. Despite high rates of initial chemotherapy response, patients often relapse due to the selection and development of chemotherapy-resistant leukemic cells. The response to therapy is currently measured after weeks to months of treatment, thereby losing important time. Now, researchers have found a new method that within hours can predict if certain cancer patients will survive or not after chemotherapy.

Researchers at the University of Bergen (Bergen, Norway) have discovered that an immediate response to chemotherapy can be measured by investigating the functional properties of the leukemic cells. In their study, the researchers employed mass cytometry to investigate intracellular signaling networks in peripheral blood samples from 32 newly-diagnosed acute myeloid leukemia patients during the first 24 hours of standardized induction chemotherapy. By correlating initial intracellular signaling response to five-year overall survival, the researchers demonstrated that early response evaluation by mass cytometry at 24 hours can identify patients with suboptimal treatment response to standard induction therapy.

"When treating patients with leukemia, it is challenging to quickly follow if the patient is responding to therapy or not," said Benedicte Sjo Tislevoll, researcher at the University of Bergen and leader of the new study. "Our results show that the protein ERK1/2 increases within the first 24 hours of chemotherapy in patients who have a poor response to therapy. We believe that this protein is responsible for the cancer cells' resistance to chemotherapy and can be used to distinguish responders from non-responders."

"We think that this is an important key in our understanding of cancer, and our aim is to use this information to change treatment early for patients who are not responding to therapy," Tislevoll concluded.

Related Links:
University of Bergen 

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
New
Gold Supplier
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
New
Silver Supplier
LED Fluorescence Microscope
EUROStar III Plus
New
Countertop Platelet Incubator
PC900-Pro

Print article
GLOBETECH PUBLISHING LLC

Channels

Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Molecular Diagnostics

view channel
Image: The ClarityDX Prostate test can reduce unnecessary prostate biopsies by up to 35% (Photo courtesy of Nanostics)

Innovative Blood Test to Revolutionize Prostate Cancer Detection and Reduce Invasive Biopsies

One in six men will receive a prostate cancer diagnosis during their lives. Thankfully, if caught early, prostate cancer is highly treatable. However, the existing screening process has its limitations.... Read more

Immunology

view channel
Image: A new test could detect the body’s adaptive immune response to viruses (Photo courtesy of 123RF)

Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form

The adaptive immune system is an incredible defense mechanism that allows the human body to identify and mount targeted responses against specific pathogens. T-Cells, a special kind of white blood cell,... Read more

Microbiology

view channel
Image: On-chip pretreatment and rapid AST based directly on positive blood cultures (Photo courtesy of Liu Yang)

Integrated Solution for Rapid AST Directly From Positive Blood Cultures to Combat Bloodstream Infection

The presence of living bacteria in the bloodstream, known as bacteremia, can lead to serious conditions like bloodstream infections (BSIs) and sepsis, which can often be fatal. Quickly prescribing the... Read more

Pathology

view channel
Image: A new microscopy method detects treatment-resistant cancer cells early (Photo courtesy of 123RF)

New Rapid-Live Screening Microscopy Technique Enables Early Detection of Treatment-Resistant Cancer Cells

Chemotherapy serves as an effective tool in the fight against cancer, yet some cancer cells can evade treatment by going into a dormant state known as senescence. These so-called therapy-induced senescent... Read more

Technology

view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more

Industry

view channel
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)

AACC Middle East 2023 to Explore Latest Trends in Clinical Pathology and Laboratory Medicine

The AACC Middle East Conference and Exposition will be held by the Association for Diagnostics & Laboratory Medicine (ADLM - formerly AACC, Washington, DC, USA) in partnership with Life Dx (Abu Dhabi,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.